E-64c Cysteine Protease Inhibitor: Preparation & Usage Protocol

E-64c is a cell-permeable, irreversible cysteine protease inhibitor widely used in biochemical and cell-based research to selectively inhibit calpains and cathepsins, enabling precise dissection of proteolytic pathways.

Inhibitor Class

Irreversible, covalent cysteine protease inhibitor

Cell Permeability

Cell-permeable (ester prodrug form of E-64)

Primary Targets

Calpain-1, Calpain-2, Cathepsin B, Cathepsin L, and related cysteine proteases

Mechanism of Action

Alkylates the active-site cysteine residue, forming an irreversible thioether bond

Recommended Solvent

DMSO or ethanol for stock solution preparation

SKU

E425884

Related Reference

E124386

Background and Mechanism of Action

E-64c is a synthetic, cell-permeable analogue of E-64, a natural epoxysuccinyl peptide originally isolated from Aspergillus japonicus. Unlike its parent compound E-64, which is membrane-impermeant, E-64c is designed as an ester prodrug that passively diffuses across cell membranes and is subsequently hydrolyzed intracellularly to release the active inhibitor E-64d (also known as EST).

E-64c acts as an irreversible, covalent inhibitor of cysteine proteases. It selectively alkylates the catalytic cysteine residue within the active site of target proteases, forming a stable thioether adduct that permanently inactivates the enzyme. Primary targets include calpain-1 (μ-calpain), calpain-2 (m-calpain), cathepsin B, and cathepsin L. Due to its selectivity for cysteine proteases over serine proteases and aspartyl proteases, E-64c is a valuable tool for dissecting protease-specific contributions to cellular processes such as apoptosis, autophagy, and lysosomal degradation.

Stock Solution Preparation

Prepare a concentrated stock solution of E-64c by dissolving the compound in a suitable anhydrous solvent immediately upon receipt or after equilibrating the vial to room temperature. The recommended solvents are anhydrous DMSO or absolute ethanol.

1. Determine target concentration: A stock concentration of 10–50 mM is typical for most applications. Consult the specific assay requirements before proceeding.
2. Calculate solvent volume: Using the molecular weight of E-64c, calculate the volume of solvent required to achieve the desired stock concentration. (Note: Confirm the exact molecular weight from the Certificate of Analysis supplied with the product, SKU E425884.)
3. Dissolve: Add the calculated volume of anhydrous DMSO or ethanol to the vial. Vortex or sonicate briefly until the compound is completely dissolved and the solution is clear.
4. Aliquot and store: Divide the stock solution into single-use aliquots in microcentrifuge tubes. Store aliquots at −20 °C, protected from light. Avoid repeated freeze-thaw cycles, which may reduce inhibitor activity.

Solubility note: E-64c exhibits good solubility in DMSO and ethanol. Aqueous solubility is limited; if aqueous preparation is required, dilute the DMSO stock into buffer immediately before use, keeping the final DMSO concentration ≤0.1% (v/v) in cell-based assays to avoid cytotoxicity.

Working Solution Preparation and Treatment Protocol

Dilute the stock solution to the desired working concentration in the appropriate assay buffer or cell culture medium immediately before use. Because E-64c is an irreversible inhibitor, accurate concentration control is essential.

For Biochemical (Cell-Free) Assays

1. Dilute the stock solution into assay buffer (e.g., 50 mM sodium phosphate, pH 6.5–7.0, or as required by the assay) to achieve a working concentration typically in the range of 1–100 μM.
2. Pre-incubate the target enzyme with E-64c at the desired concentration for 15–30 minutes at 37 °C before initiating the substrate reaction, to allow complete active-site alkylation.
3. Initiate the protease activity assay by adding the fluorogenic or chromogenic substrate according to the validated assay protocol.
4. Include appropriate vehicle controls (equivalent volume of DMSO/ethanol in buffer) and positive controls (known active enzyme without inhibitor).

For Cell-Based Assays

1. Dilute the stock solution into pre-warmed complete cell culture medium to the desired working concentration, typically 10–100 μM for most cell lines. Optimize concentration empirically for each cell type and application.
2. Remove existing medium from cells and replace with medium containing E-64c. Alternatively, add E-64c directly to existing medium if medium exchange is not feasible.
3. Incubate cells for the required duration (commonly 1–24 hours) at 37 °C, 5% CO₂. Duration depends on the biological process under investigation.
4. After treatment, proceed with downstream assays such as western blotting for calpain substrates, cathepsin activity assays, autophagy flux analysis, or apoptosis assays.

Storage, Stability, and Safety Considerations

Storage: Store the lyophilized or solid form of E-64c (SKU: E425884) at −20 °C in a tightly sealed container, protected from moisture and light. Stock solutions prepared in DMSO or ethanol should be stored at −20 °C in single-use aliquots and used within 6–12 months of preparation. Always consult the Certificate of Analysis for lot-specific storage recommendations.

Stability: E-64c is stable as a dry solid under recommended storage conditions. In solution, stability is highest in anhydrous organic solvents. Aqueous solutions should be prepared fresh immediately before use, as hydrolysis of the ester group may occur over time, reducing inhibitor potency.

Handling: Handle E-64c using standard laboratory safety precautions. Wear appropriate personal protective equipment including gloves, lab coat, and eye protection. Avoid inhalation of dust or aerosols. Work in a well-ventilated area or fume hood when handling concentrated stock solutions in DMSO.

Disposal: Dispose of E-64c and solutions containing it in accordance with local institutional and regulatory guidelines for chemical waste.

Troubleshooting

• Incomplete protease inhibition: Ensure adequate pre-incubation time (≥15 min at 37 °C) between inhibitor and enzyme before substrate addition. Verify stock solution concentration and check for degradation due to improper storage or repeated freeze-thaw cycles.
• Cytotoxicity in cell-based assays: Reduce E-64c working concentration or shorten treatment duration. Ensure the DMSO vehicle concentration does not exceed 0.1% (v/v). Include vehicle-only controls to distinguish compound-specific from solvent-related cytotoxicity.
• Poor solubility: Confirm that DMSO or ethanol used is anhydrous. If precipitate forms upon dilution into aqueous media, reduce stock concentration or use a different dilution strategy (e.g., prepare a 1 mM intermediate in buffer before final dilution).
• Inconsistent results between experiments: Use freshly prepared working solutions from aliquoted stocks. Avoid multiple freeze-thaw cycles. Confirm lot-to-lot consistency by referencing the Certificate of Analysis for each lot of E425884.

Frequently asked questions

What is the difference between E-64, E-64c, and E-64d?

E-64 is the parent natural product and is membrane-impermeant, restricting its use to cell-free biochemical assays. E-64c is a cell-permeable ester prodrug that crosses the plasma membrane and is hydrolyzed intracellularly to release E-64d (EST), the active inhibitor form. E-64d (EST) itself is also cell-permeable. E-64c and E-64d are therefore preferred for cell-based studies requiring intracellular cysteine protease inhibition.

Which proteases does E-64c inhibit?

E-64c irreversibly inhibits cysteine proteases, with primary targets including calpain-1 (μ-calpain), calpain-2 (m-calpain), cathepsin B, and cathepsin L. It does not significantly inhibit serine proteases (e.g., trypsin, chymotrypsin) or aspartyl proteases (e.g., pepsin). This selectivity makes it a useful tool for attribution studies in proteolytic pathway research.

Can E-64c inhibition be reversed?

No. E-64c acts as an irreversible inhibitor by forming a covalent thioether bond with the active-site cysteine of target proteases. This bond cannot be reversed by dilution, dialysis, or addition of reducing agents. For reversible cysteine protease inhibition, alternative inhibitors should be selected.

What solvent should I use to prepare E-64c stock solutions?

Anhydrous DMSO or absolute ethanol are the recommended solvents for preparing E-64c stock solutions. Aqueous solubility is limited, so stock solutions in organic solvents are preferred. When used in cell-based assays, dilute the organic solvent stock into culture medium immediately before use, keeping the final DMSO concentration at or below 0.1% (v/v).

How should E-64c (SKU E425884) be stored?

Store E-64c as a solid at −20 °C in a tightly sealed, moisture-proof container protected from light. Prepared stock solutions in DMSO or ethanol should also be stored at −20 °C as single-use aliquots to avoid repeated freeze-thaw cycles. Refer to the Certificate of Analysis for lot-specific recommendations.

References

1. Hanada K, Tamai M, Yamagishi M, Ohmura S, Sawada J, Tanaka I. Isolation and characterization of E-64, a new thiol protease inhibitor. Agric Biol Chem. 1978;42(2):523-528.
2. Barrett AJ, Kembhavi AA, Brown MA, et al. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982;201(1):189-198. PMID:7093242
3. Tamai M, Matsumoto K, Omura S, Koyama I, Ozaki Y, Hanada K. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. J Pharmacobiodyn. 1986;9(8):672-677.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.